Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Amgen Inc (AMGN)  
$318.15 9.99 (3.24%) as of 4:30 Mon 6/24


Download
   
Exchange: Nasdaq National Market
Security Type: Common
Shares Out: 585,690,000
Market Cap: 186.34(B)
Last Volume: 3,388,705 Avg Vol: 2,717,833
52 Week Range: $218.65 - $324.56
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Biotechnology

Member Indexes:
    S&P COMPOSITE 1500     NASDAQ BIOTECHNOLOGY
    NASDAQ COMPOSITE     NASDAQ-100
    S&P 100     S&P 500
    NASDAQ NNM COMPOSITE

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  499
Guru Rank Value     : 3
Guru Occurances    : 2

 

            6 Months   1 Year   2 Year  
 
Company Profile   Amgen is a biotechnology company that focuses on discovering, developing, manufacturing and delivering human therapeutics. Co.'s principal products are Enbrel® (etanercept), Prolia® (denosumab), Otezla® (apremilast), XGEVA® (denosumab), Neulasta® (pegfilgrastim), Aranesp® (darbepoetin alfa), Repatha® (evolocumab), KYPROLIS® (carfilzomib) and Nplate® (romiplostim). Co. also markets a number of other products, including among other, MVASI® (bevacizumab-awwb), Vectibix® (panitumumab), KANJINTI® (trastuzumab-anns), EVENITY® (romosozumab-aqqg), EPOGEN® (epoetin alfa), BLINCYTO® (blinatumomab), AMGEVITA™ (adalimumab), Aimovig® (erenumab-aooe), Parsabiv® (etelcalcetide) and NEUPOGEN® (filgrastim).

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 2,117 2,117 23,771 31,503
Total Sell Value $662,802 $662,802 $6,471,520 $8,438,219
Total People Sold 1 1 3 6
Total Sell Transactions 1 1 4 8
End Date 2024-03-24 2023-12-22 2023-06-23 2022-06-23

   
Records found: 2206
  Page 38 of 89  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Scott David J SVP, Gen. Counsel & Secy.   •       •      –    2014-11-04 4 GD $0.00 $0 D/D 1,000 87,726     -
   Williams R Sanders Director   •       •      –    2014-10-30 4 A $0.00 $0 D/D 309 309     -
   Patton Cynthia M SVP & CCO   •       •      –    2014-10-28 4 D $148.20 $77,360 D/D (522) 16,787     -
   Patton Cynthia M SVP & CCO   •       •      –    2014-10-26 4 D $147.26 $142,548 D/D (968) 17,309     -
   Mcnamee Brian M EVP   •       •      –    2014-10-25 4 D $147.26 $288,924 D/D (1,962) 75,356     -
   Coffman Vance D Director   •       •      –    2014-09-05 4 D $138.01 $1,135,822 D/D (8,230) 33,393     -
   Coffman Vance D Director   •       •      –    2014-09-05 4 OE $56.79 $1,135,800 D/D 20,000 41,623     -
   Tross Stuart A SVP, Human Resources   •       •      –    2014-09-01 4 D $139.38 $1,016,359 D/D (7,292) 23,022     -
   Patton Cynthia M SVP & CCO   •       •      –    2014-08-05 4 S $127.97 $338,358 D/D (2,644) 18,234     -
   Patton Cynthia M SVP & CCO   •       •      –    2014-08-05 4 OE $54.69 $148,041 D/D 2,644 20,878     -
   Harper Sean E EVP, Research & Development   •       •      –    2014-08-05 4 S $127.29 $1,782,126 D/D (14,000) 59,503     -
   De Carbonnel Francois Director   •       •      –    2014-08-05 4 D $128.65 $317,894 D/D (2,471) 22,149     -
   De Carbonnel Francois Director   •       •      –    2014-08-05 4 OE $54.69 $273,450 D/D 5,000 24,620     -
   Piacquad David SVP, Business Development   •       •      –    2014-08-03 4 D $0.00 $0 D/D (1,957) 25,711     -
   Meline David W EVP & CFO   •       •      –    2014-08-01 4 A $0.00 $0 D/D 54,161 54,161     -
   Balachandran Madhavan EVP, Operations   •       •      –    2014-07-31 4 GD $0.00 $0 D/D 4,358 34,244     -
   Balachandran Madhavan EVP, Operations   •       •      –    2014-07-31 4 GA $0.00 $0 I/I 4,358 46,101     -
   Balachandran Madhavan EVP, Operations   •       •      –    2014-07-31 4 D $130.01 $618,588 D/D (4,758) 38,602     -
   Michael A Kelly Acting CFO   •       –      –    2014-06-30 4 D $118.59 $227,574 D/D (1,919) 39,177     -
   Dittrich Thomas J.w. VP, Finance & CAO   •       •      –    2014-05-21 4 S $112.83 $465,984 D/D (4,130) 18,589     -
   Dittrich Thomas J.w. VP, Finance & CAO   •       •      –    2014-05-21 4 OE $54.69 $233,911 D/D 4,130 22,719     -
   Bradway Robert A Chairman, CEO and President   •       •      –    2014-05-12 4 B $111.77 $99,919 D/D 894 185,013 2.81     -
   Michael A Kelly Acting CFO   •       •      –    2014-04-28 4 S $110.45 $228,072 D/D (2,065) 41,041     -
   Tross Stuart A SVP, Human Resources   •       •      –    2014-04-27 4 D $111.41 $19,051 D/D (171) 30,204     -
   Scott David J SVP, Gen. Counsel & Secy.   •       •      –    2014-04-27 4 D $111.41 $116,758 D/D (1,048) 88,600     -
  2206 Records found
  Previous  30  31  32  33  34  35  36  37  38  39  Next   
  Page 38 of 89
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us